Comparing Two Doses of Glatiramer Acetate

Study Title
Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).
Teva Identifier
GA/9016 (FORTE)
ClinicalTrials.gov Identifier
NCT00337779
Study Status
Completed
Trial Condition(s)
Relapsing Remitting Multiple Sclerosis
Interventions
Drug: Glatiramer Acetate (GA) 40 mg | Drug: glatiramer acetate 20 mg

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 55 Years
Trial Duration
08/01/2006 - 10/01/2008
Phase
Phase 3

Study Type

Interventional